$PFE Headlines Judge likely to throw the book at
Post# of 72749
Posted On: 02/10/2014 11:28:46 AM
$PFE Headlines
Judge likely to throw the book at Martoma, experts say 4:00 p.m. Feb. 6, 2014 - blogs.marketwatch.com
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Stock market live blog: Indexes break 2-day losing streak; Kors, Yum climb 3:43 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow after an upgrade on promising cancer-drug tests 11:07 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow with 3% gain following upgrade 10:11 a.m. Feb. 4, 2014 - Russ Britt
Pfizer leads Dow with 3.3% gain following upgrade 10:03 a.m. Feb. 4, 2014 - Russ Britt
Pfizer advances 4.2% at the open, leads Dow 9:33 a.m. Feb. 4, 2014 - Victor Reklaitis
U.S. stocks see worst selloff in several months 4:41 p.m. Feb. 3, 2014 - Anora Mahmudova
Biggest drops since June for Dow industrials, S&P 500: stock market live blog recap 4:26 p.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer, Randgold gain in slumping stock market 3:52 p.m. Feb. 3, 2014 - Saumya Vaishampayan
Pfizer shares get a boost on positive results for breast-cancer treatment 10:37 a.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer breast-cancer study meets endpoint 8:37 a.m. Feb. 3, 2014 - MarketWatch.com
The inscrutable gold timers 10:26 a.m. Jan. 30, 2014 - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Dividend Stocks: Safety or Sabotage? 33 min ago - TheStreet.com
PBYI: Why Puma Biotechnology Shares Are Soaring 4:09 a.m. Today - InvestorPlace.com
FDA Panel to Weigh Painkillers' Cardiac Risk 4:32 p.m. Feb. 9, 2014 - WSJ.com
Now Everything Is Crystal Clear 2:46 a.m. Feb. 9, 2014 - Seeking Alpha
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. Feb. 7, 2014 - TheStreet.com
Dow 30 Stock Roundup: Disney Stars, Chevron Tanks - Analyst Blog 11:12 a.m. Feb. 7, 2014 - Zacks.com
The Best of Blackrock Funds: 4 Top Funds 8:26 a.m. Feb. 7, 2014 - InvestorPlace.com
Martoma Convicted in Historic Insider-Trading Case 2:21 p.m. Feb. 6, 2014 - FOXBusiness
Emerging Market Misery And U.S. Large-Cap Euphoria 12:23 p.m. Feb. 6, 2014 - Seeking Alpha
March 14th Options Now Available For Pfizer (PFE) 10:53 a.m. Feb. 6, 2014 - TheStreet.com
Irving Kahn's Kahn Brothers' Top Five Stocks at Year-End 9:34 a.m. Feb. 6, 2014 - GuruFocus.com
The 4 Stocks That Dominated the Market on Wednesday 3:43 p.m. Feb. 5, 2014 - 247WallSt.com
Merck in Pacts to Study Cancer Treatment 2:48 p.m. Feb. 5, 2014 - WSJ.com
Merck Misses on Earnings by a Penny - Analyst Blog 12:12 p.m. Feb. 5, 2014 - Zacks.com
5 Stocks Pushing The Drugs Industry Downward 12:03 p.m. Feb. 5, 2014 - TheStreet.com
Merck Q4 Misses, But Cancer Deals Ignite Stock 10:48 a.m. Feb. 5, 2014 - Investors Business Daily
Stock Market News for February 05, 2014 - Market News 10:06 a.m. Feb. 5, 2014 - Zacks.com
Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer 10:05 a.m. Feb. 5, 2014 - FOXBusiness
Dow Today: Merck (MRK) Leads The Day Higher, Pfizer (PFE) Lags 10:00 a.m. Feb. 5, 2014 - TheStreet.com
Healthcare Stocks: No Longer a Sure Thing 7:50 a.m. Feb. 5, 2014 - InvestorPlace.com
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
LiveWorld and Pfizer to Present a Series of Panels on Social Media Within Regulated Industries at Social Media Week 10:00 a.m. Feb. 4, 2014 - BusinessWire - BZX
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
TrendingWallStreet.com Initiates Trend Analysis on GFOX, CMCSA, SKTO, and PFE 12:22 a.m. Feb. 4, 2014 - ACCESSWIRE
Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Judge likely to throw the book at Martoma, experts say 4:00 p.m. Feb. 6, 2014 - blogs.marketwatch.com
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
The big Merck news centers on cancer-drug collaborations with other giants 11:02 a.m. Feb. 5, 2014 - blogs.marketwatch.com
Merck 4Q profit falls on weaker sales 8:21 a.m. Feb. 5, 2014 - MarketWatch.com
Stock market live blog: Indexes break 2-day losing streak; Kors, Yum climb 3:43 p.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow after an upgrade on promising cancer-drug tests 11:07 a.m. Feb. 4, 2014 - blogs.marketwatch.com
Pfizer leads Dow with 3% gain following upgrade 10:11 a.m. Feb. 4, 2014 - Russ Britt
Pfizer leads Dow with 3.3% gain following upgrade 10:03 a.m. Feb. 4, 2014 - Russ Britt
Pfizer advances 4.2% at the open, leads Dow 9:33 a.m. Feb. 4, 2014 - Victor Reklaitis
U.S. stocks see worst selloff in several months 4:41 p.m. Feb. 3, 2014 - Anora Mahmudova
Biggest drops since June for Dow industrials, S&P 500: stock market live blog recap 4:26 p.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer, Randgold gain in slumping stock market 3:52 p.m. Feb. 3, 2014 - Saumya Vaishampayan
Pfizer shares get a boost on positive results for breast-cancer treatment 10:37 a.m. Feb. 3, 2014 - blogs.marketwatch.com
Pfizer breast-cancer study meets endpoint 8:37 a.m. Feb. 3, 2014 - MarketWatch.com
The inscrutable gold timers 10:26 a.m. Jan. 30, 2014 - Mark Hulbert
Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Dividend Stocks: Safety or Sabotage? 33 min ago - TheStreet.com
PBYI: Why Puma Biotechnology Shares Are Soaring 4:09 a.m. Today - InvestorPlace.com
FDA Panel to Weigh Painkillers' Cardiac Risk 4:32 p.m. Feb. 9, 2014 - WSJ.com
Now Everything Is Crystal Clear 2:46 a.m. Feb. 9, 2014 - Seeking Alpha
Pfizer Inc (PFE): Today's Featured Drugs Winner 5:00 p.m. Feb. 7, 2014 - TheStreet.com
Dow 30 Stock Roundup: Disney Stars, Chevron Tanks - Analyst Blog 11:12 a.m. Feb. 7, 2014 - Zacks.com
The Best of Blackrock Funds: 4 Top Funds 8:26 a.m. Feb. 7, 2014 - InvestorPlace.com
Martoma Convicted in Historic Insider-Trading Case 2:21 p.m. Feb. 6, 2014 - FOXBusiness
Emerging Market Misery And U.S. Large-Cap Euphoria 12:23 p.m. Feb. 6, 2014 - Seeking Alpha
March 14th Options Now Available For Pfizer (PFE) 10:53 a.m. Feb. 6, 2014 - TheStreet.com
Irving Kahn's Kahn Brothers' Top Five Stocks at Year-End 9:34 a.m. Feb. 6, 2014 - GuruFocus.com
The 4 Stocks That Dominated the Market on Wednesday 3:43 p.m. Feb. 5, 2014 - 247WallSt.com
Merck in Pacts to Study Cancer Treatment 2:48 p.m. Feb. 5, 2014 - WSJ.com
Merck Misses on Earnings by a Penny - Analyst Blog 12:12 p.m. Feb. 5, 2014 - Zacks.com
5 Stocks Pushing The Drugs Industry Downward 12:03 p.m. Feb. 5, 2014 - TheStreet.com
Merck Q4 Misses, But Cancer Deals Ignite Stock 10:48 a.m. Feb. 5, 2014 - Investors Business Daily
Stock Market News for February 05, 2014 - Market News 10:06 a.m. Feb. 5, 2014 - Zacks.com
Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer 10:05 a.m. Feb. 5, 2014 - FOXBusiness
Dow Today: Merck (MRK) Leads The Day Higher, Pfizer (PFE) Lags 10:00 a.m. Feb. 5, 2014 - TheStreet.com
Healthcare Stocks: No Longer a Sure Thing 7:50 a.m. Feb. 5, 2014 - InvestorPlace.com
Pfizer And Merck To Collaborate On Innovative Anti-Cancer Combination Studies 6:45 a.m. Feb. 5, 2014 - BusinessWire - BZX
Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014 10:48 p.m. Feb. 4, 2014 - GlobeNewswire
LiveWorld and Pfizer to Present a Series of Panels on Social Media Within Regulated Industries at Social Media Week 10:00 a.m. Feb. 4, 2014 - BusinessWire - BZX
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
TrendingWallStreet.com Initiates Trend Analysis on GFOX, CMCSA, SKTO, and PFE 12:22 a.m. Feb. 4, 2014 - ACCESSWIRE
Pfizer Announces Positive Top-Line Results From PALOMA-1 Evaluating Palbociclib Plus Letrozole in Women with Advanced Breast Cancer 7:00 a.m. Feb. 3, 2014 - BusinessWire - BZX
Critical Alerts For Twitter, Alexion Pharmaceuticals, Pfizer, Ctrip, and AngloGold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 31, 2014 - PR Newswire - PRF
Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
(0)
(0)